Table 2.
Susceptibility tests.
| Clonal Complex | Strain | Number | PEN | OXA | FOX | GEN | TOB | CIP | LEV | MOX | ERY | CLI | LIN | TEI | VAN | TET | FOS | NIF | FUS | MUP | RIF | TSU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CC06 | CC6-MRSA-IV | 1 | R | R | R | S | S | S | S | S | R | R a | S | S | S | S | S | S | S | S | S | S |
| CC22 | CC22-MRSA-IV (PVL+/tst+) | 5 | R | R | R | R | R | R | R | R | VAR b | VAR ab | S | S | S | S | S | S | S | S | S | VAR c |
| CC772 | CC772-MRSA-V (PVL+), “Bengal Bay” | 1 | R | R | R | R | R | R | R | R | I | S | S | S | S | S | S | I | S | S | S | R |
| CC15 | CC15-MSSA | 1 | R | S | S | S | S | R | R | R | R | R a | S | S | S | S | S | S | S | S | S | S |
| CC96 | CC96-MSSA | 1 | S | S | S | S | S | S | S | S | R | S | S | S | S | S | S | S | S | S | S | S |
| CC2990 | CC2990-MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 01 | ST(4-13-1-105-11-5-x)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | I | S | S | S | S |
| UNKNOWN 02 | ST(1-421-1-1-12-238-11)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 03 | ST(1-3-1-15-28-x-1)-MSSA | 4 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 04 | MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 05 | ST(1-1-1-1-28-4-11)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 06 | ST(1-421-1-x-x-1-11)-MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 07 | ST(12-x-1-66-11-x-x)-MSSA | 3 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 08 | ST(1-38-1-1-x-238-x)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | I | S | S | S | S |
| UNKNOWN 09 | ST(3-3-1-66-28-x-x)-MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 10 | ST(3-1-1-66-28-1-x)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 11 | MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 12 | ST(4-421-1-105-1-5-x)-MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 13 | ST(1-3-1-x-1-1-11)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | I | S | S | S | S |
| UNKNOWN 14 | ST(3-38-1-15-1-x-40)-MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 15 | ST(1-421-1-1-12-1-11)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 16 | ST(3-3-1-66-4-1-x)-MSSA | 2 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
| UNKNOWN 17 | MSSA | 1 | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S | S |
PEN, Benzylpenicillin; OXA, Oxacillin; FOX, Cefoxitin; GEN, Gentamicin; TOB, Tobramycin; CIP, Ciprofloxacin; LEV, Levofloxacin; MOX, Moxifloxacin; ERY, Erythromycin; CLI, Clindamycin; LIN, Linezolid; TEI, Teicoplanin; VAN, Vancomycin; TET, Tetracycline; FOS, Fosfomycin; NIF, Nitrofurantoin; FUS, Fusidic acid; MUP, Mupirocin; RIF, Rifampicin and TSU, Trimethoprim/Sulfamethoxazole a Inducible clindamycin resistance. b Variable, four out of five isolates resistant (ERY)/inducibly resistant (CLI); one susceptible. c Variable, three out of five isolates resistant, two susceptible. The actual MICs are found in Supplementary Table S2.